胰岛素强化治疗的大型临床研究

被引:9
作者
张饰
李玉秀
机构
[1] 北京协和医院内分泌科
关键词
胰岛素; 糖尿病; Treat-to-Target; LANMET; AT.LANTUS; INITIATE; 1-2-3研究;
D O I
暂无
中图分类号
R587.2 [糖尿病性昏迷及其他并发症];
学科分类号
100201 [内科学];
摘要
<正>糖尿病控制和并发症试验(DCCT)和英国前瞻性糖尿病研究(UKPDS)的结果一致表明,强化血糖控制可以减少1型和2型糖尿病微血管并发症的发生率[1,2],在大血管并发症方面尚未得
引用
收藏
页码:113 / 115
页数:3
相关论文
共 4 条
[1]
Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies.[J].Melanie Davies;Patrick Sinnassamy;Fred Storms;Ramon Gomis.Diabetes Research and Clinical Practice.2007, 2
[2]
Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study [J].
Yki-Järvinen, H ;
Kauppinen-Mäkelin, R ;
Tiikkainen, M ;
Vähätalo, M ;
Virtamo, H ;
Nikkilä, K ;
Tulokas, T ;
Hulme, S ;
Hardy, K ;
McNulty, S ;
Hänninen, J ;
Levänen, H ;
Lahdenperä, S ;
Lehtonen, R ;
Ryysy, L .
DIABETOLOGIA, 2006, 49 (03) :442-451
[3]
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study [J].
Stratton, IM ;
Adler, AI ;
Neil, HAW ;
Matthews, DR ;
Manley, SE ;
Cull, CA ;
Hadden, D ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :405-412
[4]
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853